{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:17:07Z","timestamp":1787984227339,"version":"build-2784847793"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AG065653"],"award-info":[{"award-number":["R21AG065653"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01AG078615"],"award-info":[{"award-number":["R01AG078615"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neurobiolaging.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T14:54:37Z","timestamp":1729349677000},"page":"13-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Amyloid pathology and cognitive impairment in hA\u03b2-KI and APPSAA-KI mouse models of Alzheimer's disease"],"prefix":"10.1016","volume":"145","author":[{"given":"Wenyan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Shue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aishe","family":"Kurti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suren","family":"Jeevaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse R.","family":"Macyczko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Izhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.10.005_bib1","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41380-019-0410-8","article-title":"Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta","volume":"25","author":"Arber","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2024.10.005_bib2","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1002\/alz.13844","article-title":"Sex and gender differences in cognitive resilience to aging and Alzheimer's disease","volume":"20","author":"Arenaza-Urquijo","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.10.005_bib3","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1038\/s41467-021-22624-z","article-title":"Generation of a humanized Abeta expressing mouse demonstrating aspects of Alzheimer's disease-like pathology","volume":"12","author":"Baglietto-Vargas","year":"2021","journal-title":"Nat. Commun."},{"issue":"6405","key":"10.1016\/j.neurobiolaging.2024.10.005_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.neurobiolaging.2024.10.005_bib5","doi-asserted-by":"crossref","first-page":"6198","DOI":"10.1093\/hmg\/ddv336","article-title":"Tau deposition drives neuropathological, inflammatory and behavioral abnormalities independently of neuronal loss in a novel mouse model","volume":"24","author":"Cook","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2024.10.005_bib6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","article-title":"Animal models of neurodegenerative diseases","volume":"21","author":"Dawson","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.10.005_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1756-6606-3-34","article-title":"Sex- and brain region-specific acceleration of beta-amyloidogenesis following behavioral stress in a mouse model of Alzheimer's disease","volume":"3","author":"Devi","year":"2010","journal-title":"Mol. Brain"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2024.10.005_bib8","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","article-title":"Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease","volume":"35","author":"Dinkins","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.neurobiolaging.2024.10.005_bib9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","article-title":"Sex differences in Alzheimer disease - the gateway to precision medicine","volume":"14","author":"Ferretti","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2024.10.005_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","article-title":"Rodent models for Alzheimer disease","volume":"19","author":"Gotz","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2024.10.005_bib11","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","article-title":"The amyloid-beta pathway in Alzheimer's disease","volume":"26","author":"Hampel","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2024.10.005_bib12","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.jalz.2019.05.011","article-title":"Genetic resilience to Alzheimer's disease in APOE epsilon4 homozygotes: a systematic review","volume":"15","author":"Huq","year":"2019","journal-title":"Alzheimers Dement."},{"issue":"42","key":"10.1016\/j.neurobiolaging.2024.10.005_bib13","doi-asserted-by":"crossref","first-page":"28176","DOI":"10.1074\/jbc.M803159200","article-title":"The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity","volume":"283","author":"Jan","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.10.005_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer's disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"22","key":"10.1016\/j.neurobiolaging.2024.10.005_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174290","article-title":"Mitochondria-sequestered Abeta renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease","volume":"8","author":"Jia","year":"2023","journal-title":"JCI Insight"},{"issue":"7715","key":"10.1016\/j.neurobiolaging.2024.10.005_bib16","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1038\/d41586-018-05722-9","article-title":"The search for better animal models of Alzheimer's disease","volume":"559","author":"King","year":"2018","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.neurobiolaging.2024.10.005_bib17","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/hmg\/9.18.2589","article-title":"Nonfibrillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease","volume":"9","author":"Kumar-Singh","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"19","key":"10.1016\/j.neurobiolaging.2024.10.005_bib18","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/emboj.2010.211","article-title":"Neurotoxicity of Alzheimer's disease abeta peptides is induced by small changes in the Abeta42 to Abeta40 ratio","volume":"29","author":"Kuperstein","year":"2010","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.10.005_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/s41467-020-15120-3","article-title":"Amyloid-beta42\/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease","volume":"11","author":"Kwak","year":"2020","journal-title":"Nat. Commun."},{"issue":"613","key":"10.1016\/j.neurobiolaging.2024.10.005_bib20","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9375","article-title":"APOE3-jacksonville (V236E) variant reduces self-aggregation and risk of dementia","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2024.10.005_bib21","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41590-023-01640-9","article-title":"Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease","volume":"24","author":"Liu","year":"2023","journal-title":"Nat. Immunol."},{"issue":"10248","key":"10.1016\/j.neurobiolaging.2024.10.005_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2024.10.005_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3233\/JAD-230218","article-title":"Upregulation of sFRP1 is more profound in female than male 5xFAD mice and positively associated with amyloid pathology","volume":"95","author":"Macyczko","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2024.10.005_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nlm.2016.07.001","article-title":"Cognitive deficits in single app knock-in mouse models","volume":"135","author":"Masuda","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.10.005_bib25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer's disease in the APP gene at the n-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.10.005_bib26","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","article-title":"Understanding the impact of sex and gender in Alzheimer's disease: a call to action","volume":"14","author":"Nebel","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2024.10.005_bib27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nn0901-887","article-title":"The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced abeta protofibril formation","volume":"4","author":"Nilsberth","year":"2001","journal-title":"Nat. Neurosci."},{"issue":"40","key":"10.1016\/j.neurobiolaging.2024.10.005_bib28","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2024.10.005_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a model-ad study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.10.005_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13024-023-00599-3","article-title":"Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology","volume":"18","author":"Qiao","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.10.005_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40478-021-01154-1","article-title":"Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer's pathophysiology","volume":"9","author":"Ramanan","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.10.005_bib32","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single app knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"17","key":"10.1016\/j.neurobiolaging.2024.10.005_bib33","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.15252\/embj.201797397","article-title":"APP mouse models for Alzheimer's disease preclinical studies","volume":"36","author":"Sasaguri","year":"2017","journal-title":"EMBO J."},{"issue":"23","key":"10.1016\/j.neurobiolaging.2024.10.005_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm6155","article-title":"An isogenic panel of App knock-in mouse models: profiling beta-secretase inhibition and endosomal abnormalities","volume":"8","author":"Watamura","year":"2022","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2024.10.005_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2024.10.005_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-022-00547-7","article-title":"Novel app knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia","volume":"17","author":"Xia","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2024.10.005_bib37","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jmb.2006.09.046","article-title":"Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity","volume":"364","author":"Yan","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"529","key":"10.1016\/j.neurobiolaging.2024.10.005_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates alpha-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"Zhao","year":"2020","journal-title":"Sci. Transl. Med."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024001817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458024001817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T01:15:41Z","timestamp":1731978941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458024001817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":38,"alternative-id":["S0197458024001817"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.10.005","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloid pathology and cognitive impairment in hA\u03b2-KI and APPSAA-KI mouse models of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}